Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liver Fibrosis and Inflammation under the Control of ERK2
Kuo‐Shyang Jeng, Ssu-Jung Lu, Chih-Hsuan Wang, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3796-3796
Open Access | Times Cited: 25

Showing 25 citing articles:

TGF‐β as a driver of fibrosis: physiological roles and therapeutic opportunities
Erine H. Budi, Johanna Schaub, Martin Decaris, et al.
The Journal of Pathology (2021) Vol. 254, Iss. 4, pp. 358-373
Open Access | Times Cited: 171
A guide to ERK dynamics, part 2: downstream decoding
Abhineet Ram, Devan Murphy, Nicholaus DeCuzzi, et al.
Biochemical Journal (2023) Vol. 480, Iss. 23, pp. 1909-1928
Open Access | Times Cited: 19
Unraveling the hepatic stellate cells mediated mechanisms in aging's influence on liver fibrosis
Reham M. Wahid, Nancy Hassan, Walaa Samy, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Naringenin is a Potential Immunomodulator for Inhibiting Liver Fibrosis by Inhibiting the cGAS-STING Pathway
Li Chen, Siwei Xia, Shuqi Wang, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 18
Cyclo(His-Pro): A further step in the management of steatohepatitis
Alessia De Masi, Xiaoxu Li, Dohyun Lee, et al.
JHEP Reports (2023) Vol. 5, Iss. 9, pp. 100815-100815
Open Access | Times Cited: 10
Potential improvement of Isaria cicadae Miquel spores oil(ICSO)alleviate TNBS-induced fibrosis of Caco-2 cells by down-regulating the activation of EGFR and SRC in the MEK/ERK and PI3K/Akt pathways
B Wang, Hui Cao, Chao Guo, et al.
Journal of Functional Foods (2025) Vol. 128, pp. 106850-106850
Closed Access
Y-box binding protein 1 promotes chromatin accessibility to aggravate liver fibrosis
Zihui Tang, Bo-Wen Lin, Wei Li, et al.
Cellular Signalling (2023) Vol. 109, pp. 110750-110750
Closed Access | Times Cited: 9
Research on the effectiveness and material basis of Ligusticum chuanxiong in alleviating acute liver injury
Lingzhi Lu, Taotao Lu, Yajing Wu, et al.
Journal of Ethnopharmacology (2023) Vol. 314, pp. 116643-116643
Closed Access | Times Cited: 8
Familiarity Breeds Strategy: In Silico Untangling of the Molecular Complexity on Course of Autoimmune Liver Disease-to-Hepatocellular Carcinoma Transition Predicts Novel Transcriptional Signatures
Soumyadeep Mukherjee, Arpita Kar, Najma Khatun, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 1917-1917
Open Access | Times Cited: 20
Protective Effect of Liposomal Epigallocatechin-Gallate in Experimental Gentamicin-Induced Hepatotoxicity
Adriana Elena Bulboacă, Alina Porfire, Vasile Rus, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 412-412
Open Access | Times Cited: 12
Traditional Chinese medicine targets on hepatic stellate cells for the treatment of hepatic fibrosis: A mechanistic review
Dengcheng Hui, Lu Liu, Yanqin Bian, et al.
Portal hypertension & cirrhosis (2023) Vol. 2, Iss. 1, pp. 16-31
Open Access | Times Cited: 6
Combined quercetin and simvastatin attenuate hepatic fibrosis in rats by modulating SphK1/NLRP3 pathways
Yasmin Abdelbaset Salama, Hanan M. Hassan, Amal M. El-Gayar, et al.
Life Sciences (2023) Vol. 337, pp. 122349-122349
Closed Access | Times Cited: 6
Role of Cytokines on the Progression of Liver Fibrosis in Mice Infected with Echinococcus multilocularis
Fengming Tian, Tao Jiang, Xinwei Qi, et al.
Infection and Drug Resistance (2021) Vol. Volume 14, pp. 5651-5660
Open Access | Times Cited: 13
Knockdown of circ_0001679 alleviates lipopolysaccharide-induced MLE-12 lung cell injury by regulating the miR-338-3p/ mitogen-activated protein kinase 1 axis
Shenggui Lu, Xinmiao Wu, Shuai Xin, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 5803-5817
Open Access | Times Cited: 9
Oxyberberine suppressed the carbon tetrachloride-induced liver fibrosis by inhibiting liver inflammation in a sirtuin 3-dependent manner in mice
Sicheng Zhao, Jidan Li, Xiaoxiao Xing, et al.
International Immunopharmacology (2023) Vol. 116, pp. 109876-109876
Closed Access | Times Cited: 4
Network Pharmacology and Molecular Docking Reveal the Mechanism of Isodon ternifolius (D. Don) Kudo Against Liver Fibrosis
Jiasheng Deng, Le Qin, Zhipin Zhou
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 2335-2351
Open Access | Times Cited: 4
Network Pharmacology-Based Exploration on the Intervention of Qinghao Biejia Decoction on the Inflammation-Carcinoma Transformation Process of Chronic Liver Disease via MAPK and PI3k/AKT Pathway
Xin Cheng, Zhongxiao Han, Zi-Jie Su, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-23
Open Access | Times Cited: 7
Pharmacological inhibition of the Src homology phosphatase 2 confers partial protection in a mouse model of alcohol-associated liver disease
Ming-Fo Hsu, Shinichiro Koike, Chang-Shan Chen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116590-116590
Open Access | Times Cited: 1
Forkhead domain inhibitory-6 attenuates subconjunctival fibrosis in rabbit model with trabeculectomy
Chunlin Lan, Junkai Tan, Li Tang, et al.
Experimental Eye Research (2021) Vol. 210, pp. 108725-108725
Closed Access | Times Cited: 9
Strictosamide ameliorates LPS-induced acute lung injury by targeting ERK2 and mediating NF-κB signaling pathway
Qi Geng, Bin Liu, Danping Fan, et al.
Journal of Ethnopharmacology (2023) Vol. 322, pp. 117593-117593
Open Access | Times Cited: 3
Dendrobium officinale polysaccharide regulated hepatic stellate cells activation and liver fibrosis by inhibiting the SMO/Gli 1 pathway
Xiawen Yang, Wenting Ji, Zhihong Zhou, et al.
Journal of Functional Foods (2023) Vol. 112, pp. 105960-105960
Open Access | Times Cited: 3
Identifying the Mechanism of Polygoni Cuspidati Rhizoma et Radix in Treating Acute Liver Failure Based on Network Pharmacology and Molecular Docking
Jing Hong, Jie Ding, Han-han Hong, et al.
Gastroenterology Research and Practice (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 5
Expression and Correlation of MIF and ERK1/2 in Liver Cirrhosis and Hepatocellular Carcinoma Induced by Hepatitis B
Dong Jia, Bin Li, Junke Wang, et al.
Pharmacogenomics and Personalized Medicine (2023) Vol. Volume 16, pp. 381-388
Open Access | Times Cited: 2
Polyenylphosphatidylcholine as bioactive excipient in tablets for the treatment of liver fibrosis
Ivo Skorup, Gina Valentino, Simone Aleandri, et al.
International Journal of Pharmaceutics (2023) Vol. 646, pp. 123473-123473
Open Access | Times Cited: 2
Troglitazone inhibits hepatic oval cell proliferation by inducing cell cycle arrest through Hippo/YAP pathway regulation
Yifeng He, Haijian Li, HE Yun-he, et al.
Digestive and Liver Disease (2021) Vol. 54, Iss. 6, pp. 791-799
Closed Access | Times Cited: 4
Page 1

Scroll to top